Why did pension funds demand Musk's 40-hour workweek?
How will Trump’s chip sales ban affect Nvidia?
What impact does Salesforce’s AI-driven sales forecast have?
Why did the US rescind crypto 401(k) plan restrictions?
How are tariffs influencing US retail price hikes?
What caused Victoria’s Secret’s recent security incident?
Why is GameStop investing $500M in Bitcoin?
How are US visa restrictions targeting foreign censorship?
Why did Abercrombie & Fitch cut revenue outlook?
Breaking The Pain Barrier: Lilly's Acquisition Of SiteOne Aims For Opioid Alternatives
benzinga.com/general/biotech/25/05/45629147/breaking-the-pain-barrier-lillys-acquisition-of-siteone-aims-for-opioid-alternatives
Eli Lilly And Co (NYSE:LLY) on Tuesday agreed to acquire SiteOne Therapeutics, Inc., a private biotechnology company developing small-molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders.
The transaction includes STC-004, a Phase 2 ready…
This story appeared on benzinga.com, 2025-05-27 19:32:43.